The proteolytic activity of MMP9 was indicated as a key component of the regulation of cancer-related cell–cell and cell–ECM interactions by MMP9-dependent processing of E-cadherin and integrins and promoting EMT processes [75,102]. This evidence concerns the gene CDH1 and cancer.